Dr. Christopher Kauffman

Urologist 🇲🇽 @INCMNSZMX | Robotic & Lap Surgery Fellowship @IMMontsouris 🇫🇷 | HoLEP | Urology Professor @TecSaludMX | Golfer

[Fernando GomezSancha @fgomsan]

Tranexamic acid (TXA) useful only in anticoagulated patients: OR 0.17 for bleeding complications. P0731 study, 932 patients, 30 centres. Game changer for high-risk enucleation. Should probably be standard protocol. "Efficacy of tranexamic acid in reducing intraoperative bleeding during TURP: systematic review and meta-analysis of RCTs." 2026.→ PMID: 41695713 → https://t.co/H4qpfhbRUl but "Efficacy of tranexamic acid in reducing intraoperative bleeding during TURP: systematic review and meta-analysis of RCTs." 2026.
→ PMID: 41695713 → https://t.co/H4qpfhbRUl

[UroToday.com @urotoday]

Radical prostatectomy vs radiotherapy in high-risk #ProstateCancer: Emulated randomized comparison with individual patient data from two phase III randomized trials.

- A new emulated RCT analysis finds that radiotherapy + long-term ADT results in lower distant metastasis rates vs. radical prostatectomy in high-risk #ProstateCancer.
- ~80% of surgery patients required additional treatment. More data needed on intensified multimodal approaches.

Presented by @Soum_Roy_RadOnc @RushCancer. #GU25 written coverage by @zklaassen_md @GACancerCenter > https://t.co/PaL8Rfvd5G @ASCO

[Juan Gómez Rivas @JGomezRivas]

External validation of nomograms for predicting lymph node invasion (LNI) in prostate cancer patients with negative PSMA PET-CT. What did we find? The Briganti 2023 nomogram is the most accurate! 📊✅

🔍 Why does it matter?
Extended pelvic lymph node dissection (ePLND) is the gold standard for staging but comes with risks. With PSMA PET-CT revolutionizing imaging, we need better predictive tools to avoid unnecessary procedures.

📌 Key Findings:
•Among 282 patients, 13% had LNI despite negative PSMA PET-CT.
•The Briganti 2023 nomogram outperformed others (C-index: 77% vs. MSKCC 64%, Briganti 2017 69%, Amsterdam-Brisbane-Sydney 64%).
•Using a 5% risk cutoff would spare 47% of ePLND procedures while missing only 3.8% of LNI cases! 🚫🔬

⚖️ Clinical Impact:
•Improves decision-making: More precise risk stratification means fewer unnecessary surgeries.
•Saves patients from complications: ePLND has side effects; avoiding it when possible is crucial.
•Guides personalized treatment: Selecting the right patients for ePLND enhances care quality.

👨‍⚕️ Takeaway: The Briganti 2023 nomogram should be the go-to tool for predicting LNI in prostate cancer patients with negative PSMA PET-CT! 📈

🔗 Read the full study here: https://t.co/VrfJ25sjFX

#ProstateCancer #Urology #PSMAPET #LymphNodeDissection #Nomogram

[Alberto @almagoch]

Subestudio POISE 3: El uso del ácido tranexámico en #Cirugía general, un bolo al inicio y otro al final, disminuye significativamente el riesgo de #sangrado perioperatorio, sin aumentar la incidencia de eventos tromboembólicos. @JAMA_current 2025 #Cirujanos

[Matt Cooperberg @dr_coops]

Cancer Statistics 2025 are out! #prostatecancer incidence still on the rise, mortality basically flat. Get screened so you can get treatment _when needed_. #pcsm
https://t.co/CS7SKz6Tuc

[European Urology @EUplatinum]

Spotlight: EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent by @philcornford et al

Full article here: https://t.co/fhb75q5xQL

#eauguidelines #ProstateCancer #PCa #eauguidelines2024update #Spotlightarticle #eururol #urosome #MedTwitter

[European Urology @EUplatinum]

SPOTLIGHT: Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial by @nickva1

Read the full article here: https://t.co/kfk0Gsu9CQ

#UroSoMe #MedTwitter #eururol #EditorsChoice #spotlight

@GGiannarini @PellegrinoMD

[Fernando GomezSancha @fgomsan]

Many urologists struggle to understand laser physics relevant to enucleation. Watch this fantastic talk https://t.co/ngg44Kq2rX by Associate Professor @eug20miglia on endourological lasers in tissue applications. He simplifies laser physics and goes straight to the point. It's a must-see talk for every urologist who uses lasers for the treatment of urological conditions.

[John W. Davis, MD @jdhdavis]

Nice summary of where we are with the DRE. Academic urologists--do you still ask your team to include with their H&P?

Is Era of the Digital Rectal Examination (DRE) for Prostate ... : JU Open Plus https://t.co/NOstAfUuXh

[European Urology Oncology @EurUrolOncol]

Comparing the Performance of Digital Rectal Examination and Prostate-specific Antigen as a Screening Test for Prostate Cancer: A Systematic Review and Meta-analysis by Akihiro Matsukawa et al

https://t.co/xcIgyxDRtZ

#UroSoMe #MedTwitter #EUO #PCa #ProstateCancer

[NEJM @NEJM]

Many patients with prostate cancer detected by systematic biopsy have clinically insignificant disease. A screening strategy based on prostate-specific antigen & MRI could decrease detection of insignificant cancer. Learn more in a new Quick Take video: https://t.co/MOUhxpSvLC

[Prostate Imaging @ImagingProstate]

Results after Four Years of Screening for Prostate Cancer with PSA and MRI | New England Journal of Medicine https://t.co/s2jd5MYLN9

[European Urology @EUplatinum]

Spotlight: A Detailed Evaluation of the Effect of Prostate-specific Antigen–based Screening on Morbidity and Mortality of Prostate Cancer: 21-year Follow-up Results of the Rotterdam Section of the European Randomised Study of Screening for Prostate Cancer by @IvodeVos , Annick Meertens et al

Watch all our Spotlights here: https://t.co/T4jVPWYuUT

#Spotlight #UroSoMe #MedTwitter

[Dr. Christopher Kauffman @kauffmanMD]

Reunión anual de médicos egresados del INCMNSZ @INCMNSZ_Uro @aminnsz @DrFRodriguezCov @DemerolIV

[Ashwin Rajenesh MD @ashwinrajenesh]

"Is there a doctor on the plane?"✈️🩺
Responding to in-flight medical emergencies.
#MedTwitter

[European Association of Urology (EAU) @Uroweb]

When MRI is positive (i.e. PI-RADS ≥ 4), combine targeted biopsy with perilesional sampling.

#ProstateCancer #EAUguidelines

https://t.co/ZX0mFEc6wG

[European Urology Oncology @EurUrolOncol]

PCa–specific and All-cause Mortality After Robot-assisted Radical Prostatectomy: 20 Years’ Report from the European Association of Urology Robotic Urology Section Scientific Working Group by @UFalagario, @sophieknipper et al

https://t.co/H25cqq757a

#UroSoMe #MedTwitter #EUO

[Dr. Christopher Kauffman @kauffmanMD]

👏🏻👏🏻

[UHN Plus @UHN_Plus]

🇪🇸 | HISTÓRICO

Médico español extirpa un tumor renal a un paciente en China desde 8.000 km de distancia usando un robot. ¡Primera cirugía transcontinental del mundo de este tipo!

[Dr. Christopher Kauffman @kauffmanMD]

Un gran día, dos trasplantes renales con este gran equipo médico @FranciscoReyna @CesarCuen Dr Oscar Acevedo

[Eur Urol Focus @EurUrolFocus]

Evolution of robotic urology in Germany:
🖥️ 150,432 robot-assisted vs 733,416 open surgeries
📉less ICU admissions, transfusions, and length of hospital stay
📊increasing uptake across all procedures

@LMU_Muenchen @pyrgidis @gb_schulz

https://t.co/imXpvHp3l2